Investors who purchased ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, face an August 24, 2026, deadline to seek lead plaintiff status. The class action lawsuit, filed by Schall, Brown & Schwartz LLP, alleges the company misled the market regarding its actual demand and product performance.
A class action lawsuit filed against Genius Group Limited accuses the company of orchestrating a spoofing scheme to artificially inflate market activity. Investors who purchased GNS shares between April 12, 2022, and May 30, 2025, now face an August 28, 2026, deadline to join the litigation seeking recovery for their losses.
Investors who purchased Genius Group Limited securities between April 12, 2022, and May 30, 2025, face an August 28, 2026, deadline to join a class action lawsuit. The litigation, spearheaded by the firm Schall Brown & Schwartz, targets the company for alleged market manipulation and securities law violations.
Investors who purchased Insulet Corporation securities between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a class action lawsuit. The litigation, filed by Schall Brown & Schwartz, alleges the medical device company misled shareholders regarding manufacturing safety and product defects.
Investors who purchased Insulet Corporation stock between February 21, 2025, and May 26, 2026, are facing a deadline to join a class action lawsuit. The litigation alleges the company violated federal securities laws by issuing misleading statements regarding its internal manufacturing controls and product safety standards.
Investors who purchased Photronics, Inc. shares between December 10, 2025, and May 27, 2026, are facing a critical deadline to join a class action lawsuit. The DJS Law Group is currently organizing shareholders to address allegations that the company provided false and misleading financial forecasts during this period.
Shareholders who acquired Photronics, Inc. stock between December 10, 2025, and May 27, 2026, face a September 4, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation targets alleged misrepresentations regarding the company’s internal growth projections and operational capacity.
Investors who purchased Planet Fitness shares between November 6, 2025, and May 6, 2026, are being urged to join a securities class action lawsuit. The filing alleges the gym operator misled the market regarding the effectiveness of its marketing campaigns and the implementation of its national Black Card price hikes.
Investors who purchased GPGI, Inc. shares between November 3, 2025, and May 6, 2026, face a critical September 15 deadline to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on claims that the company misled the market regarding its acquisition of Husky Technologies.
Investors who held DNOW Inc. shares as of August 5, 2025, have until October 2, 2026, to seek lead plaintiff status in a class action lawsuit. The litigation targets alleged misrepresentations regarding integration hurdles following the company’s merger with MRC Global Inc. that impacted shareholder value.
Shareholders who purchased GPGI, Inc. stock between November 3, 2025, and May 6, 2026, face a September 15, 2026, deadline to join a class action lawsuit. The litigation, led by Schall Brown & Schwartz LLP, alleges the company misled investors regarding the financial health and value of its Husky Technologies acquisition.
Investors who held DNOW Inc. stock leading up to the company’s September 2025 special meeting are being urged to join a class action lawsuit. The litigation alleges that the energy equipment provider misled shareholders regarding the integration hurdles of its merger with MRC Global Inc.
Investors who purchased Rackspace Technology stock between May 7 and July 8, 2026, are being urged to join a class action lawsuit filed against the cloud computing firm. The litigation claims the company misled shareholders regarding its financial health while aggressively redirecting resources toward artificial intelligence initiatives.
A federal securities class action lawsuit now targets Rackspace Technology, Inc. over allegations of misleading financial disclosures. Shareholders who acquired RXT stock between May 7, 2026, and July 8, 2026, face an upcoming September 28, 2026, deadline to seek appointment as lead plaintiff in the ongoing litigation.
Shareholders who purchased Pentair plc stock between April 28 and July 14, 2026, face an October 2 deadline to join a class action lawsuit. The litigation alleges the company misled the market regarding significant destocking issues within its Pool channel, which negatively impacted financial performance and share value.
Investors who purchased Capricor Therapeutics stock between December 17, 2025, and July 26, 2026, are being urged to join a class action lawsuit. The firm Schall, Brown & Schwartz LLP claims the company misled shareholders regarding the statistical analysis of its lead drug candidate, Deramiocel, ahead of an FDA review.
Geopolitical shifts and central bank decisions rarely align with the traditional Monday-to-Friday trading schedule, prompting STARTRADER to debut XAUUSD247. The new CFD instrument offers investors continuous gold quotes throughout the weekend, bridging the gap between standard market sessions and the volatile events that frequently occur while global exchanges remain closed.
Investors who purchased Wix.com stock between February 19, 2025, and May 12, 2026, face an upcoming September 22 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the actual development costs and competitive standing of its proprietary artificial intelligence tools.
Investors who purchased Wix.com Ltd. shares between February 19, 2025, and May 12, 2026, face an approaching September 22, 2026, deadline to seek lead plaintiff status in a class action lawsuit. Schall, Brown & Schwartz LLP is representing shareholders alleging the company misled the market regarding its AI business operations.
A new class action lawsuit alleges that Capricor Therapeutics misled shareholders by altering clinical trial statistical plans for its drug, Deramiocel, without prior FDA approval. The litigation, filed in federal court, centers on claims that the company disseminated false information between December 17, 2025, and July 26, 2026.
Shareholders who acquired Pentair plc stock between April 28 and July 14, 2026, face a critical October 2 deadline to join a class action lawsuit. The litigation alleges the company issued materially misleading statements regarding financial performance amid a significant destocking of its pool channel products.
A class action lawsuit has been filed against EquipmentShare.com Inc. following allegations that the company obscured related-party transactions. Shareholders who acquired EQPT stock between January 23 and June 23, 2026, are now being urged to evaluate their legal standing before the September 21 filing deadline.
A federal class action lawsuit alleges PROCEPT BioRobotics misled investors by inflating revenue through aggressive discounting tactics. The complaint claims the company pulled sales forward from future periods, resulting in a significant inventory glut that rendered its public financial disclosures false and materially misleading throughout the two-year class period.
A class action lawsuit alleges that Cogent Communications Holdings, Inc. misled shareholders by inflating its backlog with unlikely revenue-generating orders. The litigation, centered on claims of false statements made between February 2024 and May 2026, invites investors to seek potential recovery for losses incurred during the period.
Dizal will present new clinical data for its EGFR inhibitor ZEGFROVY at the 2026 World Conference on Lung Cancer in Seoul, highlighting its potential in early-stage disease and combination therapies. The findings arrive as the company moves to expand the drug's reach beyond its current status as a later-line treatment.
With a strategic push into the premium display market, Hisense has released its 2026 E8S ULED MiniLED lineup, debuting on Amazon with aggressive launch pricing. The series targets a broad audience by blending high-end gaming specifications with cinema-grade visual standards and a proprietary AI-driven processing engine.
In Brewster, Washington, a remote medical facility is challenging the trend of rural hospital closures by maintaining comprehensive, 24/7 care. An upcoming segment of the Public Television series "All Access hosted by Andy Garcia" documents how this independent hub serves its community without the backing of a large urban system.
Investors holding First Solar, Inc. securities are facing an August 24, 2026, deadline to join a class action lawsuit against the company. The litigation concerns allegations that the manufacturer misled shareholders regarding its capacity to navigate international trade tariffs and relocate operations from Southeast Asia to the United States.
3SBio reported a robust first half of 2026, with adjusted operating net profit climbing 26.5% to RMB 1.44 billion. The company accelerated its international footprint, fueled by a 43% surge in overseas sales and the rapid global clinical progression of its flagship anti-PD-1/VEGF bispecific antibody, SSGJ-707.
RayNeo is bifurcating its augmented reality portfolio, moving away from universal devices toward specialized hardware. The company announced the upcoming September 4 launch of the RayNeo iO, an ambient productivity assistant, and the RayNeo GT Series, a high-fidelity spatial cinema system designed to capture distinct segments of the consumer market.
